NAMPT and gestational diabetes: This finding is not in agreement with the existing data in the literature, which show that the levels of this molecule are influenced by the presence of obesity, that visfatin values increase during the gestational period, and in pregnancies with pathologies associated with the gestation period such as gestational diabetes mellitus [36].